EP300 and hepatocellular carcinoma: Treatment of hepatocellular carcinoma cells with the highly potent p300 inhibitor B029-2 significantly reduced the levels of H3K18ac and H3K27ac and significantly reduced the proliferation and metastatic capacity of hepatocellular carcinoma cells [71].